HTA240 An Evaluation of the Reimbursement Status of CAR-T Cell Therapies in the EU-4 and UK
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.1923
https://www.valueinhealthjournal.com/article/S1098-3015(23)05053-2/fulltext
Title :
HTA240 An Evaluation of the Reimbursement Status of CAR-T Cell Therapies in the EU-4 and UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05053-2&doi=10.1016/j.jval.2023.09.1923
First page :
Section Title :
Open access? :
No
Section Order :
11367